- Home
- LEG vs ELVN Comparison
LEG vs ELVN Comparison
Compare LEG & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEG
- ELVN
- Stock Information
- Founded
- LEG 1883
- ELVN 2016
- Country
- LEG United States
- ELVN United States
- Employees
- LEG N/A
- ELVN N/A
- Industry
- LEG Home Furnishings
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- LEG Consumer Discretionary
- ELVN Health Care
- Exchange
- LEG Nasdaq
- ELVN Nasdaq
- Market Cap
- LEG 1.2B
- ELVN 1.2B
- IPO Year
- LEG N/A
- ELVN 2020
- Fundamental
- Price
- LEG $8.88
- ELVN $21.35
- Analyst Decision
- LEG Hold
- ELVN Strong Buy
- Analyst Count
- LEG 4
- ELVN 5
- Target Price
- LEG $10.50
- ELVN $41.20
- AVG Volume (30 Days)
- LEG 1.5M
- ELVN 421.5K
- Earning Date
- LEG 10-27-2025
- ELVN 11-12-2025
- Dividend Yield
- LEG 2.25%
- ELVN N/A
- EPS Growth
- LEG N/A
- ELVN N/A
- EPS
- LEG 1.02
- ELVN N/A
- Revenue
- LEG $4,238,200,000.00
- ELVN N/A
- Revenue This Year
- LEG N/A
- ELVN N/A
- Revenue Next Year
- LEG $0.46
- ELVN $20.05
- P/E Ratio
- LEG $8.69
- ELVN N/A
- Revenue Growth
- LEG N/A
- ELVN N/A
- 52 Week Low
- LEG $6.48
- ELVN $13.30
- 52 Week High
- LEG $13.62
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- LEG 47.95
- ELVN 57.25
- Support Level
- LEG $8.70
- ELVN $19.98
- Resistance Level
- LEG $8.97
- ELVN $22.42
- Average True Range (ATR)
- LEG 0.26
- ELVN 0.95
- MACD
- LEG 0.02
- ELVN 0.17
- Stochastic Oscillator
- LEG 65.24
- ELVN 71.20
About LEG Leggett & Platt Incorporated
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.